Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (50)

2022

  1. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

2021

  1. Micrornas possibly involved in the development of bone metastasis in clear-cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 7

2019

  1. Clinical and molecular comparative study of colorectal cancer based on age-of-onset and tumor location: Two main criteria for subclassifying colorectal cancer

    International Journal of Molecular Sciences, Vol. 20, Núm. 4

  2. Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy

    Oncologist, Vol. 24, Núm. 8, pp. e784-e792

  3. Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

    JCI Insight, Vol. 1, Núm. 10

  4. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma

    Theranostics, Vol. 9, Núm. 17, pp. 4946-4958

2018

  1. Gain-of-function mutations in DNMT3A in patients with paraganglioma

    Genetics in Medicine, Vol. 20, Núm. 12, pp. 1644-1651

  2. Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer

    International Journal of Cancer, Vol. 143, Núm. 8, pp. 1954-1962

2017

  1. Estudio estadístico sobre violencia de género

    Pensamiento Matemático, Vol. 7, Núm. 1, pp. 107-127

  2. Genetic variation in the NEIL2 DNA glycosylase gene is associated with oxidative DNA damage in BRCA2 mutation carriers

    Oncotarget, Vol. 8, Núm. 70, pp. 114626-114636

  3. Multilayer OMIC Data in medullary thyroid carcinoma identifies the STAT3 pathway as a potential therapeutic target in RETM918T Tumors

    Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1334-1345

  4. PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics

    Journal of Molecular Diagnostics, Vol. 19, Núm. 4, pp. 575-588

  5. Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer

    PLoS ONE, Vol. 12, Núm. 7

  6. Targeted sequencing reveals low-frequency variants in EPHA genes as markers of paclitaxel-induced peripheral neuropathy

    Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1227-1235

2016

  1. DNA copy number profiling reveals different patterns of chromosomal instability within colorectal cancer according to the age of onset

    Molecular Carcinogenesis, Vol. 55, Núm. 5, pp. 705-716

  2. Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers

    Oncotarget, Vol. 7, Núm. 18, pp. 25815-25825

2015

  1. Classifying early-onset colorectal cancer according to tumor location: New potential subcategories to explore

    American Journal of Cancer Research, Vol. 5, Núm. 7, pp. 2308-2313

  2. Functional and in silico assessment of MAX variants of unknown significance

    Journal of Molecular Medicine, Vol. 93, Núm. 11, pp. 1247-1255

  3. High frequency and founder effect of the CYP3A4∗20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme

    Pharmacogenomics Journal, Vol. 15, Núm. 3, pp. 288-292

  4. Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients

    Breast Cancer Research and Treatment, Vol. 149, Núm. 2, pp. 385-394